Dr. Benjamin C. Creelan shares his passion for cell therapy research and insights into current data. Read more
Pathology—and pathologic staging in particular—can be improved through multidisciplinary efforts. Read more
SABR patients were stable during the 12 months while surgical patients reported clinically significant deterioration at 6 weeks. Read more
The benefits of early palliative care have been proven. Could negative connotations of palliative care be impeding its adoption? Read more
For Dr. Jean-Charles Soria, the opportunity to make science actionable and increase its impact drove his decision to work in industry. Read more
Association aims to bring attention to the often-overlooked links between air pollution and lung cancer. Read more
Dr. Jhanelle Gray takes the reins as chair of the SWOG Lung Cancer Committee. Keep reading for more about this and other moves in thoracic oncology. Read more
In her first letter to ICLN readers, new CEO Karen Kelly discusses keys to achieving the association’s mission. Read more
The speed at which a tumor progresses may prove to be a useful tool in therapeutic decision-making. Read more
Growing treatment options for patients with late-stage lung cancer bring hope—and challenges. Read more